MY LEO PHARMA

Serial Number 79318552
Registration 6874598
700

Registration Progress

Application Filed
Jun 29, 2021
Under Examination
Approved for Publication
Aug 2, 2022
Published for Opposition
Aug 2, 2022
Registered
Oct 18, 2022

Trademark Image

MY LEO PHARMA

Basic Information

Serial Number
79318552
Registration Number
6874598
Filing Date
June 29, 2021
Registration Date
October 18, 2022
Published for Opposition
August 2, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 18, 2022
Registration
Registered
Classes
005 038 042 044

Rights Holder

LEO Pharma A/S

99
Address
Industriparken 55
DK-2750 Ballerup
DK

Ownership History

LEO Pharma A/S

Original Applicant
99
DK

LEO Pharma A/S

Owner at Publication
99
DK

LEO Pharma A/S

Original Registrant
99
DK

Legal Representation

Attorney
B. Brett Heavner

USPTO Deadlines

Next Deadline
1175 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-10-18)
Due Date
October 18, 2028
Grace Period Ends
April 18, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Mar 7, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Mar 6, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 10, 2023 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 10, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jan 18, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Oct 18, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 18, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 2, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 2, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 1, 2022 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jul 13, 2022 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jul 13, 2022 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jul 13, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 24, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 18, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 17, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 17, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 16, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 16, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 16, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 16, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 16, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 24, 2022 RFNT P REFUSAL PROCESSED BY IB Loading...
May 21, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
May 5, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 5, 2022 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 26, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 25, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 21, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 31, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Aug 27, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 26, 2021 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and for treatment of the skin
Class 038
Providing online forums for information and communication about skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin
Class 042
Scientific and medical research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; pharmaceutical research and development services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; scientific research for medical purposes in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of medical research, product development and scientific research in relation to skin diseases and treatment of the skin; pharmaceutical tests, namely, testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin
Class 044
Medical services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical, health and pharmaceutical consultation services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical tests, namely, medical testing for diagnostic or treatment purposes in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin

Additional Information

Design Mark
The mark consists of a tripartite swoosh design above the words "MY LEO PHARMA".
Pseudo Mark
MY LEO PHARMACY

Classification

International Classes
005 038 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"